Subchronic Inhalation Toxicity: 90-Day Study (OECD TG 413)

Abstract

902. This assay determines the subchronic inhalation toxicity of chemicals to provide robust data for quantitative inhalational hazard identification/characterisation. It is primarily used to derive regulatory concentrations for assessing worker risk in occupation settings. It is also used to assess human residential, transportation and environmental risk. Dosing duration is 90 days and the preferred species is the rat. Animals are exposed to test substance in inhalation chambers for six hours per day on a five day per week basis. The preferred mode of exposure is nose only, but whole body exposure may also be used. OECD TG 413 was first adopted in May 1981 and revised in September 2009. Although it has not been validated for the detection of endocrine active substances (EASs), this assay contains several endpoints that are suitable for the determination of endocrine effects. As all the endpoints are apical, it is difficult to discern mechanism of action from this test alone. Information on mechanism of action may need to be obtained from in vitro estrogen/androgen/thyroid/steroidogenesis (E,A,T,S) assays or in vivo lower tier tests such as the Uterotrophic Bioassay (UT – OECD TG 440) and the Hershberger Bioassay (H – OECD TG 441). Hormone measurements are not included in this assay.